NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b
ConclusionsLDV/SOF for HCV genotype 1b was exceptionally effective, however, NS5A RAVs undermined the virological effect for cirrhosis patients. Moreover, LDV/SOF was shown to be safe, irrespective of age or fibrosis status.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research
More News: Cirrhosis | Gastroenterology | Genetics | Hepatitis | Hepatitis C | Statistics | Study | Virology